98 related articles for article (PubMed ID: 8868957)
1. [Efficacy of pyrimethamine in monotherapy for preventing toxoplasmosis in AIDS].
De Truchis P; Flament-Saillour M; Risbourg M; Urtizberea JA; Dournon E
Presse Med; 1996 Jul 6-13; 25(24):1125. PubMed ID: 8868957
[No Abstract] [Full Text] [Related]
2. Toxoplasmosis of the bladder in a patient with AIDS.
Besnier JM; Verdier M; Cotty F; Fétissof F; Besancenez A; Choutet P
Clin Infect Dis; 1995 Aug; 21(2):452-4. PubMed ID: 8562769
[No Abstract] [Full Text] [Related]
3. [Azithromycin combined with pyrimethamine in the treatment of neurotoxoplasmosis, in an AIDS patient].
Trotta M; Sterrantino G; Milo D; Dionisio D; Leoncini F
Minerva Med; 1997 Mar; 88(3):117-9. PubMed ID: 9148227
[TBL] [Abstract][Full Text] [Related]
4. Preventing opportunistic infections.
Cheng B
PI Perspect; 1995 May; (no 16):14-5. PubMed ID: 11362422
[TBL] [Abstract][Full Text] [Related]
5. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
[TBL] [Abstract][Full Text] [Related]
6. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
[TBL] [Abstract][Full Text] [Related]
7. Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.
Chêne G; Morlat P; Leport C; Hafner R; Dequae L; Charreau I; Aboulker JP; Luft B; Aubertin J; Vildé JL; Salamon R
Control Clin Trials; 1998 Jun; 19(3):233-48. PubMed ID: 9620807
[TBL] [Abstract][Full Text] [Related]
8. Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa?
Samb B; Badiane M; Kony S; Larouzé B; Faye MA; Sow PS; Badiane S; Metro A; Costagliola D; Ndoye I; Delaporte E; Coll-Seck AM; Coulaud JP
AIDS; 1998 Mar; 12(4):447. PubMed ID: 9520181
[No Abstract] [Full Text] [Related]
9. Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids.
Arens J; Barnes K; Crowley N; Maartens G
S Afr Med J; 2007 Oct; 97(10):956-8. PubMed ID: 18000578
[TBL] [Abstract][Full Text] [Related]
10. Understanding prophylactic therapy for HIV infections.
Anastasi JK; Rivera J
Am J Nurs; 1994 Feb; 94(2):36-41; quiz 42. PubMed ID: 8304396
[No Abstract] [Full Text] [Related]
11. Duodenal and hepatic toxoplasmosis in a patient with HIV infection: review of the literature.
Bonacini M; Kanel G; Alamy M
Am J Gastroenterol; 1996 Sep; 91(9):1838-40. PubMed ID: 8792710
[TBL] [Abstract][Full Text] [Related]
12. Robust Bayesian approaches for clinical trial monitoring.
Carlin BP; Sargent DJ
Stat Med; 1996 Jun; 15(11):1093-106. PubMed ID: 8804141
[TBL] [Abstract][Full Text] [Related]
13. Early intervention therapy in HIV-infected patients: a questionnaire-based survey among French physicians.
Landman R; Olivaries R; Girard PM; Gaudebout C; Saimot AG; Coulaud JP
AIDS; 1994 Feb; 8(2):274-6. PubMed ID: 7913818
[No Abstract] [Full Text] [Related]
14. Toxoplasma pneumonia in a patient with AIDS.
Halme M; Jokipii L; Jokipii AM; Ristola M; Lähdevirta J
J Infect; 1995 Nov; 31(3):252-3. PubMed ID: 8586853
[No Abstract] [Full Text] [Related]
15. Antibiotic prophylaxis for the prevention of donor-acquired Toxoplasma gondii infection in transplant patients.
Wreghitt TG; McNeil K; Roth C; Wallwork J; McKee T; Parameshwar J
J Infect; 1995 Nov; 31(3):253-4. PubMed ID: 8586854
[No Abstract] [Full Text] [Related]
16. Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant centers.
Baran DA; Alwarshetty MM; Alvi S; Arroyo LH; Lubitz S; Pinney S; Gass AL; Zucker MJ
J Heart Lung Transplant; 2006 Nov; 25(11):1380-2. PubMed ID: 17097506
[TBL] [Abstract][Full Text] [Related]
17. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
[TBL] [Abstract][Full Text] [Related]
18. Oral trimethoprim-sulfamethoxazole in the treatment of cerebral toxoplasmosis in AIDS patients--a prospective study.
Francis P; Patel VB; Bill PL; Bhigjee AI
S Afr Med J; 2004 Jan; 94(1):51-3. PubMed ID: 14971234
[TBL] [Abstract][Full Text] [Related]
19. HIV: opportunistic infections.
Ioannidis J; Wilkinson D
Clin Evid; 2003 Jun; (9):795-816. PubMed ID: 15366175
[No Abstract] [Full Text] [Related]
20. [Prevention of toxoplasmosis in immunocompromised patients].
Morlat P; Leport C
Ann Med Interne (Paris); 1997; 148(3):235-9. PubMed ID: 9255332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
